Un pensador de nuestro tiempo

1 documento en PDF de 11 páginas.Este texto es producto de las reflexiones de varios estudiosos en torno al pensamiento del filósofo Julián Marías, quien abrió caminos al pensamiento universal, y aportó claves de especial importancia para la comprensión del ser humano en nuestros días.INTRODUCCIÓN El campo Intermedio Belisario Betancur Julián Marías: etapas de una filosofía Harold Raley El sentido del quehacer filosófico en Julián Marías Luis Fernando Fernández Ochoa Julian Marías, lector e intérprete de las Meditaciones del Quijote Helio Carpintero El valor de la palabra en Julián Marías Juan Carlos Vergara Silva La “estructura empírica”, eje del pensamiento antropológico de Julián Marías Ana María Araújo La persona en Julián Marías Jorge Aurelio Díaz Hacia una interpretación personal de la mujer Nieves Gómez Álvarez Amor-enamoramiento Ana María Araújo El Dios vivencial de Julián Marías Alejandra Peñacoba Arribas Marías y la afirmación de la persona: momentos aplicables a la antropología médica Carlos A. Gómez Fajardo La defensa de la vida en el pensamiento de Julián Marías: el caso del aborto Carlos Alberto Sampedro ¿Es de orden transcendental la antropología de Julián Marías? Juan Fernando Sellés El desafío de la ilusión ante la crisis de esperanza. La sugestiva visión de Julián Marías. A propósito del centenario de su natalicio Juan Camilo Restrepo Tamayo Julián Marías, liberal Iván Garzón Vallejo Julián Marías y la II República española Jaime Prieto La transmutación anímica de Julián Marías en su crónica de viajes Imagen de la India Ricardo Visbal Sierr

Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

Le bondheur et la quelité de la vie. A la recher che du paradis

One of the preoccupations of human beings is to find the key to happiness. Neither consumption nor collectivism nor liberalism -among other ideologies that have reigned the last century- has granted happiness to man, he has forgotten that besides having primary necessities, he is a being in need for love. Human life, that is growing, is not reduced to immanence or growth inwards. The terminal patient or the newborn boy does not have a deep capacity for privacy, nor to receive and give love. That love allows him to find the sense of his own life. He who can only donate, extend and open love to others is called a persono Happiness must be found from itself and in relations with others.-Une des préoccupations de l'etre humain est rencontrer la dé du bonheur. Ni la consommation, ni la collectivité, ni le libéralisme -entre autres idéologies qui ont prédominé le dernier siede- ont concédé le bonheur a l'homme, parce qu'ils ont oublié que I'homme est un etre qui a besoin, en plus des nécessités primaires, de l'amour. La vie humaine, qui est une croissance, ne se réduit pas a une immanence ou la croissance a l'intérieur, mais elle est aussi une croissance transcendante. Le malade terminal ou l'enfant qui n'est pas né ont une profonde capacité de l'intimité, de recevoir et de donner l'amour. Cet amour leur permet de trouver le sens de leur propre vie. C'est seulement celui qui ne peut pas étre possédé par un autre, ni par quelque chose, c'est-a-dire, quelqu'un qui est une personne, peut se donner, transcender, s'ouvrir a un autre. Le bonheur doit étre trouvé a l'intérieur de l'homme et dans les relations avec les autres

Le bonheur et la qualité de la vie. A la recherche du paradis

8 páginasQué duda cabe de una de las grandes preocupaciones del ser humano durante toda la historia ha sido encontrar la clave del paraíso, de la felicidad: la búsqueda necesaria de aquellas claves capaces de explicar la felicidad humana

Complementariedad varón y mujer

8 páginasThe author exposes some of the features of the gender ideology and discusses why neither females nor males can go against their own nature without making themselves and their lives miserable. Man and woman are two reciprocal realities, mutually referring to each other; when either of them suffers a crisis, the other one. will necessarily fall into a crisis as well. Human life exists in a disjunctive way: each one of us is either male or female, both conditions consisting of their intrinsic reciprocal reference. Being a male means bearing a reference to / being referred to a female. Being a female means having a reference to / being referred to a male.In this article, some elements are discussed in order to explain the meaning of being male or female; and why other - just cultural - gender alternatives are disjunction attempts not coinciding with the real being of a man and a woman.La autora expone algunas características de la ideología de género y argumenta por qué ni la mujer ni el varón pueden ir en contra de su propia naturaleza sin hacerse desgraciados. Hombre y mujer son dos realidades referidas recíprocamente la una a la otra; al entrar en crisis una, necesariamente entra en crisis la otra. La vida humana existe disyuntivamente: se es varón o mujer, y ambos consisten en su referencia recíproca intrínseca: ser varón es estar referido a la mujer, y ser mujer significa estar referida al varón. En el artículo se exponen algunos elementos para clarificar qué significa ser mujer y ser varón, y por qué las demás alternativas de género, solo culturales, son intentos de disyunciones que no coinciden con el ser real del varón y de la mujer

Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

Background: In early 2020, COVID-19 massively hit Italy, earlier and harder than any other European country. This caused a series of strict containment measures, aimed at blocking the spread of the pandemic. Healthcare delivery was also affected when resources were diverted towards care of COVID-19 patients, including intensive care wards. Aim of the study: The aim is assessing the impact of COVID-19 on cardiac imaging in Italy, compare to the Rest of Europe (RoE) and the World (RoW). Methods: A global survey was conducted in May–June 2020 worldwide, through a questionnaire distributed online. The survey covered three periods: March and April 2020, and March 2019. Data from 52 Italian centres, a subset of the 909 participating centres from 108 countries, were analyzed. Results: In Italy, volumes decreased by 67% in March 2020, compared to March 2019, as opposed to a significantly lower decrease (p &lt; 0.001) in RoE and RoW (41% and 40%, respectively). A further decrease from March 2020 to April 2020 summed up to 76% for the North, 77% for the Centre and 86% for the South. When compared to the RoE and RoW, this further decrease from March 2020 to April 2020 in Italy was significantly less (p = 0.005), most likely reflecting the earlier effects of the containment measures in Italy, taken earlier than anywhere else in the West. Conclusions: The COVID-19 pandemic massively hit Italy and caused a disruption of healthcare services, including cardiac imaging studies. This raises concern about the medium- and long-term consequences for the high number of patients who were denied timely diagnoses and the subsequent lifesaving therapies and procedures

Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

Objectives: The INCAPS COVID Oceania study aimed to assess the impact caused by the COVID-19 pandemic on cardiac procedure volume provided in the Oceania region. Methods: A retrospective survey was performed comparing procedure volumes within March 2019 (pre-COVID-19) with April 2020 (during first wave of COVID-19 pandemic). Sixty-three (63) health care facilities within Oceania that perform cardiac diagnostic procedures were surveyed, including a mixture of metropolitan and regional, hospital and outpatient, public and private sites, and 846 facilities outside of Oceania. The percentage change in procedure volume was measured between March 2019 and April 2020, compared by test type and by facility. Results: In Oceania, the total cardiac diagnostic procedure volume was reduced by 52.2% from March 2019 to April 2020, compared to a reduction of 75.9% seen in the rest of the world (p&lt;0.001). Within Oceania sites, this reduction varied significantly between procedure types, but not between types of health care facility. All procedure types (other than stress cardiac magnetic resonance [CMR] and positron emission tomography [PET]) saw significant reductions in volume over this time period (p&lt;0.001). In Oceania, transthoracic echocardiography (TTE) decreased by 51.6%, transoesophageal echocardiography (TOE) by 74.0%, and stress tests by 65% overall, which was more pronounced for stress electrocardiograph (ECG) (81.8%) and stress echocardiography (76.7%) compared to stress single-photon emission computerised tomography (SPECT) (44.3%). Invasive coronary angiography decreased by 36.7% in Oceania. Conclusion: A significant reduction in cardiac diagnostic procedure volume was seen across all facility types in Oceania and was likely a function of recommendations from cardiac societies and directives from government to minimise spread of COVID-19 amongst patients and staff. Longer term evaluation is important to assess for negative patient outcomes which may relate to deferral of usual models of care within cardiology

International Impact of COVID-19 on the Diagnosis of Heart Disease

Background: The coronavirus disease 2019 (COVID-19) pandemic has adversely affected diagnosis and treatment of noncommunicable diseases. Its effects on delivery of diagnostic care for cardiovascular disease, which remains the leading cause of death worldwide, have not been quantified. Objectives: The study sought to assess COVID-19's impact on global cardiovascular diagnostic procedural volumes and safety practices. Methods: The International Atomic Energy Agency conducted a worldwide survey assessing alterations in cardiovascular procedure volumes and safety practices resulting from COVID-19. Noninvasive and invasive cardiac testing volumes were obtained from participating sites for March and April 2020 and compared with those from March 2019. Availability of personal protective equipment and pandemic-related testing practice changes were ascertained. Results: Surveys were submitted from 909 inpatient and outpatient centers performing cardiac diagnostic procedures, in 108 countries. Procedure volumes decreased 42% from March 2019 to March 2020, and 64% from March 2019 to April 2020. Transthoracic echocardiography decreased by 59%, transesophageal echocardiography 76%, and stress tests 78%, which varied between stress modalities. Coronary angiography (invasive or computed tomography) decreased 55% (p &lt; 0.001 for each procedure). In multivariable regression, significantly greater reduction in procedures occurred for centers in countries with lower gross domestic product. Location in a low-income and lower–middle-income country was associated with an additional 22% reduction in cardiac procedures and less availability of personal protective equipment and telehealth. Conclusions: COVID-19 was associated with a significant and abrupt reduction in cardiovascular diagnostic testing across the globe, especially affecting the world's economically challenged. Further study of cardiovascular outcomes and COVID-19–related changes in care delivery is warranted